ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 2
In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Here are the ICM links: DOCUMENTS | ICMORTHO. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Joint Approach
ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 1
ICM Guidelines Discussion: "Is there a role for suppressive antibiotic treatment (SAT) only in patients with PJI?” Part 2
ICM Guidelines Discussion: "Is there a role for Suppressive Antibiotic Treatment only in patients with PJI?” Part 1
ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 1
Get summaries like this every morning.
Free AI-powered recaps of Joint Approach and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.